EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Oligometastatic Breast Cancer: Seeking the Cure by Redefining Stage IV Disease?

Dionysia N Zouki, Eleni A Karatrasoglou, Georgios Pilichos, Elisavet Papadimitraki

Current Treatment Options in Oncology · 2024

DOI: 10.1007/s11864-024-01275-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Treatment Options in Oncology, 2024. Verfasst von Dionysia N Zouki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Breast Unit, University College London Hospitals NHS Foundation Trust, London, UK. dzouki@med.uoa.gr. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Staging, Neoplasm Metastasis, Disease Management. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OPINION STATEMENT: Breast cancer represents one of the most common malignancies worldwide. In early stages a combination of treatment strategies are offered with curative intent, whereas the therapeutic aim in metastatic disease is to provide the longest possible survival with an acceptable quality of life. The term "oligometastasis", first described by Hellmann and Weichselbaum in 1995, represents an intermediate state between local and systemic disease, where radical focal treatments to all metastatic lesions might have a curative potential. Due to sufficient lack of data, the proper management of oligometastatic disease remains even until today a highly unmet need. Surgery, radiotherapy or ablation (radiofrequency or cryotherapy) are among the local eradication therapies that could offer long-term outcomes in patients with oligometastatic breast cancer (OMBC). The present review aims to bring the readers up to the latest data regarding the management of OMBC according to the different organs involved by setting a framework of current treatment paradigms. It also brings to the forefront debatable questions requiring multidisciplinary approach and highlights the concerns arising from dealing with this clinically and biologically unique entity in everyday clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeoplasm StagingNeoplasm MetastasisDisease ManagementHumansFemaleCombined Modality TherapyTreatment Outcome

Stichwörter der Autor:innen

Breast cancerCurative potentialLocal eradication therapiesOligometastasis

Autor:innen und Institutionen

  • Breast Unit, University College London Hospitals NHS Foundation Trust, London, UK. dzouki@med.uoa.gr.
  • Breast Unit, University College London Hospitals NHS Foundation Trust, London, UK.
  • Department of Surgery, Karlstad Central Hospital, Rosenborgsgatan 9, 65230, Karlstad, Sweden.

Zitieren

APA

Zouki, D. N., Karatrasoglou, E. A., Pilichos, G., & Papadimitraki, E. (2024). Oligometastatic Breast Cancer: Seeking the Cure by Redefining Stage IV Disease?. Current Treatment Options in Oncology. https://doi.org/10.1007/s11864-024-01275-4

Vancouver

Zouki DN, Karatrasoglou EA, Pilichos G, Papadimitraki E. Oligometastatic Breast Cancer: Seeking the Cure by Redefining Stage IV Disease?. Current Treatment Options in Oncology. 2024. doi:10.1007/s11864-024-01275-4

BibTeX
@article{Zouki2024,
  author = {Zouki, Dionysia N and Karatrasoglou, Eleni A and Pilichos, Georgios and Papadimitraki, Elisavet},
  title = {Oligometastatic Breast Cancer: Seeking the Cure by Redefining Stage IV Disease?},
  journal = {Current Treatment Options in Oncology},
  year = {2024},
  doi = {10.1007/s11864-024-01275-4}
}
Kostenlos starten →